We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Syngenta (SYT) 1H16 Earnings Fall Y/Y; ChemChina Holds Key
Read MoreHide Full Article
Syngenta AG (SYT - Free Report) reported weak first-half 2016 results. Management cited unfavorable currency translations, unstable performance in emerging markets and low crop prices as the main reasons behind the dismal half-yearly results.
For first-half 2016, Syngenta’s diluted earnings per share, excluding restructuring and impairment charges, came in at $12.69 (or $2.5 per ADR), down 14% from $14.70 in the year-ago comparable period.
Revenues
In first-half 2016, the company’s total sales were $7,094 million, down 7% year over year. Sales from Europe, Africa, and the Middle East stood at $2,692 million, down 7% year over year. North American revenues were $2,115 million, down 5% year over year. Sales from Latin American declined 11% year over year to $1,041 million. Sale in the Asia Pacific was $910 million, down 11% year over year. However, Syngenta’s Lawn & Garden sales inched up 3% year over year to $336 million.
Margins
At the end of the first half of 2016, earnings before interest, tax, depreciation and amortization (EBITDA) margin was 24.9%, down 130 basis points year over year. Operating margin was 19% compared with 20.5% at the end of the first half of 2015.
Cash Flow
Syngenta’s free cash flow came in at $337 million as against $109 million a year ago. Business working capital, as a percentage of sales, was 47% compared with 43% at the end of the first half of 2015. Capital expenditure (fixed inclusive of intangibles) was $221 million at the end of the period.
Outlook
Syngenta believes that its successful buyout by ChemChina would mitigate issues associated with difficult market conditions and make it more competent to operate amid all headwinds. In a phase where the industry is consolidating, ChemChina’s buyout offer would likely offer Syngenta a buffer at time of low grain prices or during scarcity of credit among Latin American farmers. Moreover, the takeover is expected to reinforce Syngenta’s investments in innovation and hence, solidify its product portfolio. Other than this, Syngenta intends to improve margins on the back of its strategic accelerating operational leverage (AOL) program and reduction of raw input expenses.
Share Price Impact
As of Jul 21, 2016, the closing stock price of Syngenta was $78.58 per share or 387.8 francs . The price is 20% lower than ChemChina’s bid value of 464 francs. Though the company has reported weak half-yearly results, it might not lose favor with investors’ as the ChemChina deal is expected to strengthen its business near term.
Syngenta currently carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the industry are Bunge Limited (BG - Free Report) , The Andersons, Inc. (ANDE - Free Report) and First Majestic Silver Corp. (AG - Free Report) . Bunge Limited currently sports a Zacks Rank #1 (Strong Buy), while both Andersons, Inc. and First Majestic hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Syngenta (SYT) 1H16 Earnings Fall Y/Y; ChemChina Holds Key
Syngenta AG (SYT - Free Report) reported weak first-half 2016 results. Management cited unfavorable currency translations, unstable performance in emerging markets and low crop prices as the main reasons behind the dismal half-yearly results.
For first-half 2016, Syngenta’s diluted earnings per share, excluding restructuring and impairment charges, came in at $12.69 (or $2.5 per ADR), down 14% from $14.70 in the year-ago comparable period.
Revenues
In first-half 2016, the company’s total sales were $7,094 million, down 7% year over year. Sales from Europe, Africa, and the Middle East stood at $2,692 million, down 7% year over year. North American revenues were $2,115 million, down 5% year over year. Sales from Latin American declined 11% year over year to $1,041 million. Sale in the Asia Pacific was $910 million, down 11% year over year. However, Syngenta’s Lawn & Garden sales inched up 3% year over year to $336 million.
Margins
At the end of the first half of 2016, earnings before interest, tax, depreciation and amortization (EBITDA) margin was 24.9%, down 130 basis points year over year. Operating margin was 19% compared with 20.5% at the end of the first half of 2015.
Cash Flow
Syngenta’s free cash flow came in at $337 million as against $109 million a year ago. Business working capital, as a percentage of sales, was 47% compared with 43% at the end of the first half of 2015. Capital expenditure (fixed inclusive of intangibles) was $221 million at the end of the period.
Outlook
Syngenta believes that its successful buyout by ChemChina would mitigate issues associated with difficult market conditions and make it more competent to operate amid all headwinds. In a phase where the industry is consolidating, ChemChina’s buyout offer would likely offer Syngenta a buffer at time of low grain prices or during scarcity of credit among Latin American farmers. Moreover, the takeover is expected to reinforce Syngenta’s investments in innovation and hence, solidify its product portfolio. Other than this, Syngenta intends to improve margins on the back of its strategic accelerating operational leverage (AOL) program and reduction of raw input expenses.
Share Price Impact
As of Jul 21, 2016, the closing stock price of Syngenta was $78.58 per share or 387.8 francs . The price is 20% lower than ChemChina’s bid value of 464 francs. Though the company has reported weak half-yearly results, it might not lose favor with investors’ as the ChemChina deal is expected to strengthen its business near term.
SYNGENTA AG-ADR Price, Consensus and EPS Surprise
SYNGENTA AG-ADR Price, Consensus and EPS Surprise | SYNGENTA AG-ADR Quote
Stocks to Consider
Syngenta currently carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the industry are Bunge Limited (BG - Free Report) , The Andersons, Inc. (ANDE - Free Report) and First Majestic Silver Corp. (AG - Free Report) . Bunge Limited currently sports a Zacks Rank #1 (Strong Buy), while both Andersons, Inc. and First Majestic hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>